Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI

  • Protocol
  • First Online:
Preclinical MRI

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1718))

Abstract

The integrity of the blood–brain barrier (BBB) can be noninvasively monitored by magnetic resonance imaging (MRI). Conventional MR contrast agents (CAs) containing gadolinium are used in association with MRI in routine clinical practice to detect and quantify BBB leakage. Under normal circumstances CAs do not cross the intact BBB. However due to their small size they extravasate from the blood into the brain tissue even when the BBB is partially compromised. Here we describe an MR method based on T1-weighted images taken prior to and after CA injection. This MR method is useful for investigating BBB permeability in in vivo mouse models and can be easily applied in a number of experimental disease conditions including neuroinflammation disorders, or to assess (un)wanted drug effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L (2007) Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6(8):650–661. https://doi.org/10.1038/nrd2368

    Article  CAS  PubMed  Google Scholar 

  2. Fernandez-Lopez D, Faustino J, Daneman R, Zhou L, Lee SY, Derugin N, Wendland MF, Vexler ZS (2012) Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. J Neurosci 32(28):9588–9600. https://doi.org/10.1523/JNEUROSCI.5977-11.2012

    Article  CAS  PubMed  Google Scholar 

  3. Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HB (2015) Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain 138(Pt 9):2571–2583. https://doi.org/10.1093/brain/awv203

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shlosberg D, Benifla M, Kaufer D, Friedman A (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6(7):393–403. https://doi.org/10.1038/nrneurol.2010.74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Marques F, Sousa JC, Sousa N, Palha JA (2013) Blood-brain-barriers in aging and in Alzheimer's disease. Mol Neurodegener 8:38. https://doi.org/10.1186/1750-1326-8-38

    Article  PubMed  PubMed Central  Google Scholar 

  6. Abdul Muneer PM, Alikunju S, Szlachetka AM, Murrin LC, Haorah J (2011) Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener 6:23. https://doi.org/10.1186/1750-1326-6-23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Patel JP, Frey BN (2015) Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast 2015:708306. https://doi.org/10.1155/2015/708306

    Article  PubMed  PubMed Central  Google Scholar 

  8. Banks WA (2012) Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology 153(9):4111–4119. https://doi.org/10.1210/en.2012-1435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15(4):275–292. https://doi.org/10.1038/nrd.2015.21

    Article  CAS  PubMed  Google Scholar 

  10. Blockx I, Einstein S, Guns PJ, Van Audekerke J, Guglielmetti C, Zago W, Roose D, Verhoye M, Van der Linden A, Bard F (2016) Monitoring blood-brain barrier integrity following amyloid-beta immunotherapy using gadolinium-enhanced MRI in a PDAPP mouse model. J Alzheimers Dis 54(2):723–735. https://doi.org/10.3233/JAD-160023

    Article  CAS  PubMed  Google Scholar 

  11. Chacko AM, Li C, Pryma DA, Brem S, Coukos G, Muzykantov V (2013) Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide. Expert Opin Drug Deliv 10(7):907–926. https://doi.org/10.1517/17425247.2013.808184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Absinta M, Sati P, Reich DS (2016) Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol 12(6):358–368. https://doi.org/10.1038/nrneurol.2016.59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lin Y, Pan Y, Wang M, Huang X, Yin Y, Wang Y, Jia F, **ong W, Zhang N, Jiang JY (2012) Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat. Lab Invest 92(11):1623–1634. https://doi.org/10.1038/labinvest.2012.118

    Article  CAS  PubMed  Google Scholar 

  14. Heye AK, Culling RD, Valdes Hernandez Mdel C, Thrippleton MJ, Wardlaw JM (2014) Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. NeuroImage Clin 6:262–274. https://doi.org/10.1016/j.nicl.2014.09.002

    Article  PubMed  PubMed Central  Google Scholar 

  15. Barnes SR, Ng TS, Montagne A, Law M, Zlokovic BV, Jacobs RE (2016) Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med 75(5):1967–1977. https://doi.org/10.1002/mrm.25793

    Article  CAS  PubMed  Google Scholar 

  16. Larsson HB, Courivaud F, Rostrup E, Hansen AE (2009) Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med 62(5):1270–1281. https://doi.org/10.1002/mrm.22136

    Article  PubMed  Google Scholar 

  17. Feng Y, Jeong EK, Mohs AM, Emerson L, ZR L (2008) Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice. Magn Reson Med 60(6):1347–1352. https://doi.org/10.1002/mrm.21791

    Article  PubMed  PubMed Central  Google Scholar 

  18. Niendorf T, Pohlmann A, Reimann HM, Waiczies H, Peper E, Huelnhagen T, Seeliger E, Schreiber A, Kettritz R, Strobel K, Ku MC, Waiczies S (2015) Advancing cardiovascular, neurovascular, and renal magnetic resonance imaging in small rodents using cryogenic radiofrequency coil technology. Front Pharmacol 6:255. https://doi.org/10.3389/fphar.2015.00255

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wagenhaus B, Pohlmann A, Dieringer MA, Els A, Waiczies H, Waiczies S, Schulz-Menger J, Niendorf T (2012) Functional and morphological cardiac magnetic resonance imaging of mice using a cryogenic quadrature radiofrequency coil. PLoS One 7(8):e42383. https://doi.org/10.1371/journal.pone.0042383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

The authors wish to thank Till Hülnhagen, Henning Reimann, and Joao Periquito for the development of all custom made analysis tools with MATLAB program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Pohlmann .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Ku, MC., Waiczies, S., Niendorf, T., Pohlmann, A. (2018). Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI. In: García Martín, M., López Larrubia, P. (eds) Preclinical MRI. Methods in Molecular Biology, vol 1718. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7531-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7531-0_23

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7530-3

  • Online ISBN: 978-1-4939-7531-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Navigation